Lee Tien-Li
- SEC CIK
- 0001940120
In the past year, 1 open-market purchase filing worth $101.4K and no sales.
Current role at each company
- AARD Aardvark Therapeutics, Inc.Chief Executive Officeras of Feb 11, 2026
- SCLX Scilex Holding CoDirectoras of Jan 17, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $101.4K
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$101.4K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Lee Tien-Li as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AARD Aardvark Therapeutics, Inc.
Chief Executive Officer4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2025 (view filing) | Dec 11 | 1 day | Lee Tien-LiChief Executive Officer | PPurchase | +7.00K | $14.49 | +$101.4K | +0.5%1.55M after | |
| Sep 16, 2025 (view filing) | Sep 15 | 1 day | Lee Tien-LiChief Executive Officer | PPurchase | +10.0K | $9.66 | +$96.6K | +0.7%1.54M after | 2 lots |
| Sep 12, 2025 (view filing) | Sep 10-12 | 2 days | Lee Tien-LiChief Executive Officer | PPurchase | +20.0K | $8.03 | +$160.6K | +1.3%1.53M after | 3 lots |
| Feb 19, 2025 (view filing) | Feb 14 | 5 days | Lee Tien-LiChief Executive Officer | PPurchase | +16.5K | $16.00 | +$264.7K | +1.1%1.50M after |